LIGAND PHARMACEUTICALS INC
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
LGND$314.16+0.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 4. Mine Safety Disclosures
| Item 4. | Mine Safety Disclosures |
|---|
Not applicable.
PART II
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.